Fulgent Genetics Correlations

FLGT Stock  USD 17.33  0.28  1.64%   
The current 90-days correlation between Fulgent Genetics and Caredx Inc is -0.22 (i.e., Very good diversification). The correlation of Fulgent Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.

Moving together with Fulgent Stock

  0.64VTAK Catheter PrecisionPairCorr

Moving against Fulgent Stock

  0.67ABT Abbott Laboratories Earnings Call This WeekPairCorr
  0.53MD Mednax IncPairCorr
  0.51DOCS DoximityPairCorr
  0.48GH Guardant HealthPairCorr
  0.48LH LaboratoryPairCorr
  0.39FEMY FemasysPairCorr
  0.32EHAB EnhabitPairCorr
  0.62BSX Boston Scientific CorpPairCorr
  0.59EHC Encompass Health CorpPairCorr
  0.58CON Concentra Group HoldingsPairCorr
  0.56ALC Alcon AGPairCorr
  0.54DGX Quest DiagnosticsPairCorr
  0.44CVS CVS Health CorpPairCorr
  0.34BVS BioventusPairCorr
  0.32CAH Cardinal HealthPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Fulgent Stock performing well and Fulgent Genetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fulgent Genetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Fulgent Genetics Corporate Management

Doreen NgVice ComplianceProfile
DABMG FACMGChief DirectorProfile
Paul KimChief OfficerProfile
Natalie PrescottGeneral OfficerProfile
Lawrence MDChief OfficerProfile